VitaSpring Biomedical Co. Ltd.

VSBC · OTC
Analyze with AI
10/31/2022
7/31/2022
4/30/2022
1/31/2022
Operating Activities
Net Income-$138-$144$277$941
Dep. & Amort.$4$4$4$4
Deferred Tax-$7$6-$1$37
Stock-Based Comp.$37$37$37$44
Change in WC$107$112-$416-$1,197
Other Non-Cash-$61-$72$72$65
Operating Cash Flow$2-$58-$28-$156
Investing Activities
PP&E Inv.$0$0$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0-$1
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$51
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$51
Forex Effect$0$0$0$0
Net Chg. in Cash$2-$58-$28-$107
Supplemental Information
Beg. Cash$22$79$107$214
End Cash$24$22$79$107
Free Cash Flow$2-$58-$28-$157
VitaSpring Biomedical Co. Ltd. (VSBC) Financial Statements & Key Stats | AlphaPilot